EE200200404A - Kaltsiumdikarboksülaateetrid, nende valmistamismeetodid ja vaskulaarse haiguse ning suhkurtõve ravimine nendega - Google Patents

Kaltsiumdikarboksülaateetrid, nende valmistamismeetodid ja vaskulaarse haiguse ning suhkurtõve ravimine nendega

Info

Publication number
EE200200404A
EE200200404A EEP200200404A EEP200200404A EE200200404A EE 200200404 A EE200200404 A EE 200200404A EE P200200404 A EEP200200404 A EE P200200404A EE P200200404 A EEP200200404 A EE P200200404A EE 200200404 A EE200200404 A EE 200200404A
Authority
EE
Estonia
Prior art keywords
diabetes
preparation
treatment
methods
vascular disease
Prior art date
Application number
EEP200200404A
Other languages
English (en)
Estonian (et)
Inventor
Yoshihisa Ando Howard
Jay Dozeman Gary
Eugene Butler Donald
Original Assignee
Warner-Lambert Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner-Lambert Company filed Critical Warner-Lambert Company
Publication of EE200200404A publication Critical patent/EE200200404A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/125—Saturated compounds having only one carboxyl group and containing ether groups, groups, groups, or groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/235—Saturated compounds containing more than one carboxyl group
    • C07C59/305—Saturated compounds containing more than one carboxyl group containing ether groups, groups, groups, or groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
EEP200200404A 2000-01-25 2001-01-11 Kaltsiumdikarboksülaateetrid, nende valmistamismeetodid ja vaskulaarse haiguse ning suhkurtõve ravimine nendega EE200200404A (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US17782300P 2000-01-25 2000-01-25
PCT/IB2001/000026 WO2001055078A1 (en) 2000-01-25 2001-01-11 Calcium dicarboxylate ethers, methods of making same, and treatment of vascular disease and diabetes therewith

Publications (1)

Publication Number Publication Date
EE200200404A true EE200200404A (et) 2003-10-15

Family

ID=22650106

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200200404A EE200200404A (et) 2000-01-25 2001-01-11 Kaltsiumdikarboksülaateetrid, nende valmistamismeetodid ja vaskulaarse haiguse ning suhkurtõve ravimine nendega

Country Status (39)

Country Link
EP (1) EP1259474B1 (cs)
JP (1) JP4750995B2 (cs)
KR (1) KR20020073182A (cs)
CN (1) CN1395555A (cs)
AP (1) AP2002002587A0 (cs)
AR (1) AR029436A1 (cs)
AT (1) ATE431326T1 (cs)
AU (1) AU2214001A (cs)
BG (1) BG106851A (cs)
BR (1) BR0107763A (cs)
CA (1) CA2397960C (cs)
CO (1) CO5261537A1 (cs)
CZ (1) CZ20022474A3 (cs)
DE (1) DE60138686D1 (cs)
DK (1) DK1259474T3 (cs)
DZ (1) DZ3239A1 (cs)
EA (1) EA004862B1 (cs)
EE (1) EE200200404A (cs)
ES (1) ES2324281T3 (cs)
GE (1) GEP20053428B (cs)
GT (1) GT200100015A (cs)
HN (1) HN2001000011A (cs)
HU (1) HUP0204422A3 (cs)
IL (1) IL150541A0 (cs)
IS (1) IS6442A (cs)
MA (1) MA26867A1 (cs)
MX (1) MXPA02007223A (cs)
NO (1) NO20023526L (cs)
NZ (1) NZ519550A (cs)
OA (1) OA12166A (cs)
PA (1) PA8510601A1 (cs)
PE (1) PE20011064A1 (cs)
PL (1) PL357076A1 (cs)
SK (1) SK10622002A3 (cs)
SV (1) SV2002000290A (cs)
TN (1) TNSN01013A1 (cs)
UY (1) UY26550A1 (cs)
WO (1) WO2001055078A1 (cs)
ZA (1) ZA200205880B (cs)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI1045691T1 (en) * 1997-12-12 2005-04-30 Warner-Lambert Company Llc Statin-carboxyalkylether combinations
JP2006501238A (ja) * 2002-08-22 2006-01-12 ワーナー−ランバート・カンパニー、リミテッド、ライアビリティ、カンパニー 骨関節炎を治療する方法
US7816405B2 (en) 2005-04-19 2010-10-19 Eisai R&D Management Co., Ltd. Calcium bis [(2S)-3-[3-[(2S)-3-(4-chloro-2-cyanophenoxy)-2-fluoropropoxy]phenyl ]-2-isopropoxypropionate] and intermediate thereof
JPWO2006115130A1 (ja) * 2005-04-19 2008-12-18 エーザイ・アール・アンド・ディー・マネジメント株式会社 ビス[(2s)−3−[3−[(2s)−3−(4−クロロ−2−シアノフェノキシ)−2−フルオロプロポキシ]フェニル]−2−イソプロポキシプロピオン酸]カルシウム及びその中間体
EP3218349A2 (en) * 2014-11-14 2017-09-20 Gemphire Therapeutics Inc. Processes and intermediates for preparing , -dicarboxylic acid-terminated dialkane ethers
EP3612171A4 (en) 2017-04-18 2020-10-21 Gemphire Therapeutics Inc. GEMCABENE, PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, COMPOSITIONS THEREOF AND PROCEDURES FOR THE USE OF THE SAME
JP2022505033A (ja) * 2018-10-18 2022-01-14 ジェムフィアー セラピューティクス インコーポレイテッド ゲムカベン、薬学的に許容されるその塩、その組成物、およびその使用方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5648387A (en) 1995-03-24 1997-07-15 Warner-Lambert Company Carboxyalkylethers, formulations, and treatment of vascular diseases
NZ503982A (en) 1997-12-12 2002-03-28 Warner Lambert Co Statin-carboxyalkylether combinations useful for treating vascular disorders and diabetes mellitus

Also Published As

Publication number Publication date
BR0107763A (pt) 2002-11-12
MXPA02007223A (es) 2002-11-29
IS6442A (is) 2002-06-25
DK1259474T3 (da) 2009-07-20
EA004862B1 (ru) 2004-08-26
WO2001055078A1 (en) 2001-08-02
HUP0204422A2 (en) 2003-05-28
AP2002002587A0 (en) 2002-09-30
MA26867A1 (fr) 2004-12-20
KR20020073182A (ko) 2002-09-19
PA8510601A1 (es) 2002-08-26
NZ519550A (en) 2003-11-28
JP2003520835A (ja) 2003-07-08
ATE431326T1 (de) 2009-05-15
GEP20053428B (en) 2005-01-25
EP1259474A1 (en) 2002-11-27
JP4750995B2 (ja) 2011-08-17
AR029436A1 (es) 2003-06-25
TNSN01013A1 (fr) 2005-11-10
BG106851A (en) 2003-01-31
SV2002000290A (es) 2002-07-16
ES2324281T3 (es) 2009-08-04
CO5261537A1 (es) 2003-03-31
IL150541A0 (en) 2003-02-12
AU2214001A (en) 2001-08-07
NO20023526L (no) 2002-08-27
NO20023526D0 (no) 2002-07-24
PL357076A1 (en) 2004-07-12
CA2397960C (en) 2008-09-09
UY26550A1 (es) 2001-08-27
DZ3239A1 (fr) 2001-08-02
SK10622002A3 (sk) 2003-07-01
CZ20022474A3 (cs) 2003-06-18
DE60138686D1 (de) 2009-06-25
CN1395555A (zh) 2003-02-05
EP1259474B1 (en) 2009-05-13
HUP0204422A3 (en) 2003-08-28
CA2397960A1 (en) 2001-08-02
GT200100015A (es) 2001-10-19
PE20011064A1 (es) 2001-10-22
ZA200205880B (en) 2003-07-23
OA12166A (en) 2003-11-07
EA200200641A1 (ru) 2002-12-26
HN2001000011A (es) 2001-06-13

Similar Documents

Publication Publication Date Title
DE60023043D1 (de) (S,S)-Reboxetin zur Behandlung von Inkontinenz
EE200200704A (et) Uued ühendid, meetod nende valmistamiseks ning nende kasutamine
EE200200470A (et) Uued ühendid, meetod nende valmistamiseks ning nende kasutamine
DE602004029580D1 (de) Substituierte indolderivate für eine pharmazeutische zusammensetzung zur behandlung von atemwegserkrankungen
EE05104B1 (et) Asetidiini derivaadid, nende valmistamise meetodid ja farmatseutiline kompositsioon
EE04852B1 (et) C-21 modifitseeritud epotioloonid, nende valmistamise meetod ning kasutamine ja ravimkoostise kasutamine vähkkasvajate või teiste proliferatiivsete haiguste ravimisel
EE04175B1 (et) Meetod topiramaadi farmatseutilise kompositsioonivalmistamiseks, farmatseutiline kompositsioon ning topiramaadi kasutamine diabeedi raviks ette nähtud ravimi valmistamiseks
EE200300033A (et) Tsüklopentanoindoolid, nende kasutamine ravimi valmistamiseks ning neid sisaldav farmatseutiline kompositsioon
BRPI0307673A2 (pt) métodos de tratar doença vascular.
FIU20060389U0 (fi) Luusairauksien hoito
EE200100574A (et) Uued ühendid, nende valmistamise meetod ning kasutamine
ATE451123T1 (de) Vaginal verabreichbare zusammensetzung zur behandlung von uteriner dysrhythmie
EE200100653A (et) Indolüülpiperidiinühendid, nende valmistamismeetod, kompositsioon ja nende kasutamine
DE50211137D1 (de) Seitenkettenhalogenierte aminodicarbonsaurederivate als arzneimittel zur behandlung von herz-kreislauf-erkrankungen
DE60233433D1 (de) PHARMAZEUTISCHE ZUBEREITUNG enthaltend ein Catechin, Ascorbinsäure, Prolin und Lysin ZUR BEHANDLUNG VON NEOPLASTISCHEN KRANKHEITEN
DE60016047D1 (de) Dihydrobenzopyrane, dihydrobenzothiopyrane und tetrahydrochinoline zur behandlung cox-2-abhängiger krankheiten
NO20023526L (no) Kalsium-dikarboksylatetere, fremgangsmåter for fremstilling derav, og behandling av vaskul¶r sykdom og diabetes
EE200200697A (et) Uued ühendid, meetod nende valmistamiseks ning nende kasutamine
MXPA02006511A (es) Complejo que comprende factor inhibidor de osteoclastogenesis y polisacarido.
EP1759718A4 (en) PREPARATION FOR TISSUE CLOSURE
EA200200853A1 (ru) Применение 2-метилтиазолидин-3,3-дикарбоновой кислоты (2-мтдк) и/или ее физиологически совместимых солей для лечения и/или предупреждения рака
EE200100573A (et) Uued ühendid, nende valmistamise meetod ning kasutamine
DE60105053D1 (de) Zusammensetzungen zur behandlung von gewebe
EE200100544A (et) 15-lülilised 8a- ja 9a-laktaamid, nende valmistamismeetod ja farmatseutiline kompositsioon
ITTO20000441A0 (it) Composizione terapeutica per la cura della psoriasi.